Karin Olson1, Joanne Hewit2, Linda G Slater3, Thane Chambers3, Deborah Hicks4, Anna Farmer5, Kathryn Grattan6, Shawn Steggles7, Bryan Kolb8. 1. Faculty of Nursing, 3rd Level, Edmonton Clinic Health Academy, University of Alberta, 11405 - 87 Ave., Edmonton, AB, T6G 1C9, Canada. karin.olson@ualberta.ca. 2. Cross Cancer Institute, 11560 University Avenue, Edmonton, AB, T6G 1Z2, Canada. 3. John W. Scott Health Sciences Library, University of Alberta, 2K328 WMC, Edmonton, ABT6G 2R7, Canada. 4. Department of Educational Policy Studies, Faculty of Education, University of Alberta, 7-104 Education North, Edmonton, AB, T6E 2G5, Canada. 5. Department of Agricultural, Food and Nutritional Science, Human Nutrition Division, Edmonton Clinic Health Academy, University of Alberta, 11405 - 87 Ave, Edmonton, AB, T6G 1C9, Canada. 6. St. Joseph's Health Care, 268 Grosvenor St, London, ON, N6A 4V2, Canada. 7. Department of Oncology, University of Alberta, Edmonton, AB, T6G 2R7, Canada. 8. Department of Neuroscience, University of Lethbridge, Lethbridge, AB, T1K3M4, Canada.
Abstract
PURPOSE: The purpose of this scoping review was to determine the feasibility of conducting a systematic review of approaches for screening or assessing cognitive function that were comprehensive and that could be incorporated into clinical settings. METHODS: Using the scoping review approach developed by Arksey and O'Malley, we searched Ovid Embase 1980-, Ovid PsycINFO 1806-, Ovid Health and Psychosocial Instruments 1985-, EBSCOhost CINAHL, ISI Web of Science (Science Citation Index 1900-), Social Sciences Citation Index 1900-, Conference Proceedings Citation Index -Science 1990-, Conference Proceedings Citation Index -Social Science & Humanities 1990-, Scopus 1960-, with no language restrictions. Searches were conducted in April 2009 and updated in February 2013. Studies of adults treated with chemotherapy that included at least seven of the eight domains of cognition were included. RESULTS: Eleven studies met inclusion criteria. No screening tools suitable for inclusion in a clinic were identified. The studies reviewed varied by inclusion/exclusion criteria, design, and instruments for assessing cognitive function, and thus, there are not yet enough studies to warrant a systematic review on this topic.
PURPOSE: The purpose of this scoping review was to determine the feasibility of conducting a systematic review of approaches for screening or assessing cognitive function that were comprehensive and that could be incorporated into clinical settings. METHODS: Using the scoping review approach developed by Arksey and O'Malley, we searched Ovid Embase 1980-, Ovid PsycINFO 1806-, Ovid Health and Psychosocial Instruments 1985-, EBSCOhost CINAHL, ISI Web of Science (Science Citation Index 1900-), Social Sciences Citation Index 1900-, Conference Proceedings Citation Index -Science 1990-, Conference Proceedings Citation Index -Social Science & Humanities 1990-, Scopus 1960-, with no language restrictions. Searches were conducted in April 2009 and updated in February 2013. Studies of adults treated with chemotherapy that included at least seven of the eight domains of cognition were included. RESULTS: Eleven studies met inclusion criteria. No screening tools suitable for inclusion in a clinic were identified. The studies reviewed varied by inclusion/exclusion criteria, design, and instruments for assessing cognitive function, and thus, there are not yet enough studies to warrant a systematic review on this topic.
Authors: Michiel B de Ruiter; Liesbeth Reneman; Willem Boogerd; Dick J Veltman; Frits S A M van Dam; Aart J Nederveen; Epie Boven; Sanne B Schagen Journal: Hum Brain Mapp Date: 2010-07-28 Impact factor: 5.038
Authors: Felice A Tager; Paula S McKinley; Freya R Schnabel; Mahmoud El-Tamer; Ying Keun K Cheung; Yixin Fang; Claire R Golden; Margery E Frosch; Ulya Habif; Margaret M Mulligan; Ivy S Chen; Dawn L Hershman Journal: Breast Cancer Res Treat Date: 2009-11-06 Impact factor: 4.872
Authors: Karen Nieuwenhuijsen; Angela de Boer; Evelien Spelten; Mirjam A G Sprangers; Jos H A M Verbeek Journal: Psychooncology Date: 2009-06 Impact factor: 3.894
Authors: S B Schagen; M J Muller; W Boogerd; R M Rosenbrand; D van Rhijn; S Rodenhuis; F S A M van Dam Journal: Ann Oncol Date: 2002-09 Impact factor: 32.976